+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Epoetin Beta"

Global Anemia Drugs Market by Drug (Alglucerase Injection, Carbonyl Iron, Cyanocobalamin), Type (Aplastic Anemia, Chronic Kidney Disease Anemia, Hemolytic Anemia), Route of Administration, End-Users - Forecast 2024-2030 - Product Thumbnail Image

Global Anemia Drugs Market by Drug (Alglucerase Injection, Carbonyl Iron, Cyanocobalamin), Type (Aplastic Anemia, Chronic Kidney Disease Anemia, Hemolytic Anemia), Route of Administration, End-Users - Forecast 2024-2030

  • Report
  • March 2024
  • 197 Pages
  • Global
From
Drug Overview: NeoRecormon - Product Thumbnail Image

Drug Overview: NeoRecormon

  • Drug Pipelines
  • January 2018
  • 8 Pages
  • Global
From
Epoetin-beta Erythropoietin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Epoetin-beta Erythropoietin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 107 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Epoetin Beta is a type of hematological drug used to treat anemia caused by chemotherapy, kidney failure, and other conditions. It is a recombinant form of erythropoietin, a hormone produced by the kidneys that stimulates the production of red blood cells. Epoetin Beta is administered intravenously or subcutaneously and is used to increase the number of red blood cells in the body. It is also used to reduce the need for blood transfusions in patients with anemia. Epoetin Beta is available in both brand-name and generic forms. Brand-name versions include Epogen, Procrit, and Binocrit. Generic versions include Retacrit and NeoRecormon. Epoetin Beta is manufactured by several companies, including Amgen, Johnson & Johnson, Pfizer, Roche, and Sandoz. Show Less Read more